2019 Q1 Form 10-Q Financial Statement

#000106299320002162 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2019 Q1
Revenue $180.8M
YoY Change -42.19%
Cost Of Revenue $277.1M
YoY Change -0.67%
Gross Profit $13.71M
YoY Change -59.31%
Gross Profit Margin 7.58%
Selling, General & Admin $26.20M
YoY Change -7.38%
% of Gross Profit 191.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.300M
YoY Change 1.95%
% of Gross Profit 60.56%
Operating Expenses $29.30M
YoY Change 3.58%
Operating Profit -$15.59M
YoY Change -388.99%
Interest Expense -$7.600M
YoY Change -192.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $35.10M
YoY Change -670.27%
Income Tax $9.500M
% Of Pretax Income 27.07%
Net Earnings $25.65M
YoY Change -687.88%
Net Earnings / Revenue 14.19%
Basic Earnings Per Share $0.27
Diluted Earnings Per Share $0.26
COMMON SHARES
Basic Shares Outstanding 87.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.000M
YoY Change 106.9%
Cash & Equivalents $6.015M
Short-Term Investments
Other Short-Term Assets $31.50M
YoY Change -17.97%
Inventory $329.9M
Prepaid Expenses
Receivables $120.3M
Other Receivables $7.100M
Total Short-Term Assets $494.8M
YoY Change -6.34%
LONG-TERM ASSETS
Property, Plant & Equipment $239.0M
YoY Change 45.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.300M
YoY Change -58.75%
Total Long-Term Assets $426.9M
YoY Change -5.47%
TOTAL ASSETS
Total Short-Term Assets $494.8M
Total Long-Term Assets $426.9M
Total Assets $921.7M
YoY Change -5.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.9M
YoY Change -21.39%
Accrued Expenses $17.40M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $224.0M
YoY Change -5.33%
Long-Term Debt Due $1.800M
YoY Change -17.81%
Total Short-Term Liabilities $381.6M
YoY Change -8.36%
LONG-TERM LIABILITIES
Long-Term Debt $228.4M
YoY Change 1.25%
Other Long-Term Liabilities $60.20M
YoY Change 2408.33%
Total Long-Term Liabilities $288.6M
YoY Change 27.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $381.6M
Total Long-Term Liabilities $288.6M
Total Liabilities $687.2M
YoY Change 4.25%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $234.6M
YoY Change
Total Liabilities & Shareholders Equity $921.7M
YoY Change -5.94%

Cashflow Statement

Concept 2019 Q1
OPERATING ACTIVITIES
Net Income $25.65M
YoY Change -687.88%
Depreciation, Depletion And Amortization $8.300M
YoY Change 1.95%
Cash From Operating Activities $990.0K
YoY Change -86.81%
INVESTING ACTIVITIES
Capital Expenditures -$7.970M
YoY Change -218.34%
Acquisitions
YoY Change
Other Investing Activities $64.88M
YoY Change
Cash From Investing Activities $56.90M
YoY Change -1042.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$55.10M
YoY Change 2954.16%
NET CHANGE
Cash From Operating Activities 990.0K
Cash From Investing Activities 56.90M
Cash From Financing Activities -$55.10M
Net Change In Cash -$55.10M
YoY Change 16445.65%
FREE CASH FLOW
Cash From Operating Activities $990.0K
Capital Expenditures -$7.970M
Free Cash Flow $8.960M
YoY Change 1062.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L5N 2X7
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
89170844 shares
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1298000 USD
CY2019Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
43512000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-54000 USD
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88225036 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
88089733 shares
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-163000 USD
CY2020Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2286000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
45579000 USD
CY2020Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-20654000 USD
CY2019Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-4801000 USD
CY2019Q1 stkl Proceeds On Notes Receivable From Sale Of Business
ProceedsOnNotesReceivableFromSaleOfBusiness
64876000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9689000 USD
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-54661000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1852000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
101000 USD
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
228000 USD
CY2019Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
314000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55097000 USD
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div> <div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><i><b>Basis of Presentation</b></i></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">These interim consolidated financial statements of SunOpta Inc. (the "Company" or "SunOpta") have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X promulgated under the Securities Exchange Act of 1934, as amended, and in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information. Accordingly, these condensed interim consolidated financial statements do not include all of the disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, all adjustments considered necessary for fair presentation have been included and all such adjustments are of a normal, recurring nature. Operating results for the quarter ended March 28, 2020 are not necessarily indicative of the results that may be expected for the full fiscal year ending January 2, 2021, or for any other period. The interim consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries and have been prepared on a basis consistent with the annual consolidated financial statements for the year ended December 28, 2019. For further information, refer to the consolidated financial statements, and notes thereto, included in the Company's Annual Report on Form 10-K for the fiscal year ended December 28, 2019.</span></span></p> <p style="font-size: 10pt; font-family: Times New Roman, Times, serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">As described in note 13, in the fourth quarter of 2019, the Company changed its segment reporting to reflect changes to its operating structure. All segment information presented in these consolidated financial statements for the quarter ended March 30, 2019 has been restated to reflect the new segment reporting structure.</span></span></p> </div> </div>
CY2020Q1 us-gaap Operating Cycle
OperatingCycle
The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal year 2020 is a 53-week period ending on January 2, 2021, with quarterly periods ending on March 28, June 27 and September 26, 2020. Fiscal year 2019 was a 52-week period ending on December 28, 2019, with quarterly periods ending on March 30, June 29 and September 28, 2019.
CY2020Q1 us-gaap Inventory Recall Expense
InventoryRecallExpense
0 USD
CY2019Q1 us-gaap Inventory Recall Expense
InventoryRecallExpense
260000 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1298000 USD
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2000000 USD
CY2019Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
2100000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2020Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
11333333 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
11333333 shares
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-4211000 USD
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4621000 USD
CY2019Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-4801000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
77000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q1 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
1700000 USD
CY2019Q1 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
0 USD
CY2020Q1 stkl Dividends Preferred Stock Cash Accrued And Unpaid
DividendsPreferredStockCashAccruedAndUnpaid
0 USD
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1298000 USD

Files In Submission

Name View Source Status
0001062993-20-002162-index-headers.html Edgar Link pending
0001062993-20-002162-index.html Edgar Link pending
0001062993-20-002162.txt Edgar Link pending
0001062993-20-002162-xbrl.zip Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stkl-20200328.xsd Edgar Link pending
stkl-20200328_cal.xml Edgar Link unprocessable
stkl-20200328_def.xml Edgar Link unprocessable
stkl-20200328_lab.xml Edgar Link unprocessable
stkl-20200328_pre.xml Edgar Link unprocessable